About this trial
This study explored the association between postoperative functional recovery and the formula of analgesic pumps as well as other related factors (such as age, intraoperative blood loss, operation duration, etc.) by retrospectively analyzing the clinical data of patients undergoing cesarean section in the main campus and branches of Sichuan Provincial People's Hospital from September 2024 to June 2025. The value of this study lies in: 1) providing a basis for optimizing the postoperative analgesia plan after cesarean section. 2) To provide references for the formulation of personalized analgesia strategies in clinical practice, improve the postoperative recovery quality of patients, promote the concept of enhanced recovery after surgery, and reduce the medical burden.
Eligibility criteria
Qualifiers
Age 18-55 years
ASAI-III level
Scheduled or emergency cesarean section
Postoperative use of analgesic pump (formulation includes buprenorphine or tramadol or hydromorphone, etc.)
Disqualifiers
Postoperative analgesia pump usage time is less than 24 hours
Missing key information such as follow-up status in medical records
Trial design
Treatments tested in this trial
- An postoperative analgesic pump was used